Selank

Selank

10mg / Vial
£25.00
Sale price  £25.00 Regular price 
Skip to product information
Selank

Selank

£25.00
Sale price  £25.00 Regular price 
Size10mg
Type
For Research Purposes Only — Not For Human Use This product is intended solely for laboratory and in-vitro research. Not for human consumption, medical use, or self-administration.
Third-party tested
1–2 day tracked dispatch
Discreet packaging
99%+ purity guaranteed
For Research Use OnlyThis compound is strictly for laboratory and in-vitro research. Not for human consumption or medical use.
Reconstitution
Pen format? Pens are supplied pre-mixed and ready for research use — no reconstitution required. The steps below apply to lyophilized vials only.
  1. Swab both vial stoppers with alcohol and allow to dry.
  2. Draw the required volume of bacteriostatic water with a sterile syringe.
  3. Add the water slowly down the inside wall of the vial — never directly onto the powder.
  4. Swirl gently until fully dissolved. Never shake.
  5. Confirm the solution is clear and particle-free.
  6. Label with date and concentration, then refrigerate at 2–8 °C.
Full guide & dose calculator
Storage & Handling
  • Lyophilized vials: refrigerate sealed at 2–8 °C away from light; freeze at −20 °C for storage beyond 6 months.
  • After reconstitution: refrigerate at 2–8 °C; typically stable 4–8 weeks with bacteriostatic water. Do not freeze once mixed.
  • Pre-mixed pens: arrive ready to use — refrigerate at 2–8 °C with the cap on and never freeze.
  • General: avoid direct sunlight, heat and repeated temperature swings; minimise agitation.
Quality & Shipping FAQ
  • Is this compound tested? Yes — every batch is third-party tested by accredited labs (HPLC & mass spectrometry) at 99%+ verified purity.
  • How is it supplied? As lyophilized powder in a sealed sterile vial (or pre-mixed pen where offered), with research-use labelling.
  • How fast is dispatch? 1–2 working day dispatch, 2–3 days UK delivery, in plain discreet packaging.
  • What is it for? Strictly laboratory and in-vitro research — not for human or veterinary consumption, medical use or self-administration.
View the peer-reviewed research
Packaging update Our branded boxes are temporarily out of stock. Until new stock lands, orders ship in plain, discreet packaging — the same product inside, sealed and dispatched with the same care. Thank you for your patience.

Selank

Selank is a synthetic peptide derived from the naturally occurring immunomodulatory peptide tuftsin. It is used as a reference compound in neuropeptide research.

About the compound

Selank is studied in laboratory research for its interactions within neuropeptide and related signalling pathways. As a synthetic analogue of a naturally occurring peptide fragment, it remains a subject of ongoing research in these areas.

Specifications

  • Purity: 99%+ (third-party verified)
  • Independently tested before dispatch
  • Presented as lyophilised (freeze-dried) powder
  • Supplied for in-vitro laboratory research only

FAQ

Is it tested? Yes — every batch is independently tested to 99%+ purity before dispatch.
What form does it arrive in? Lyophilised powder.
What is this sold for? Laboratory and research use only. Not for human or animal consumption.

⚖ For Laboratory Research Use Only — Not for Human Consumption.

Peer-Reviewed Evidence

Research & Studies

Independent published research on Selank

Selank Cognitive Research Human Clinical

Selank Demonstrates Anxiolytic and Cognitive Benefits Without Sedation in Human Patients

Journal of Neurology and Psychiatry (S.S. Korsakov) · Semenova et al., 2009

Clinical evaluation in patients with generalised anxiety disorder demonstrated significant reductions in anxiety scores, improved mood, and enhanced memory and attention vs controls. Unlike benzodiazepines, Selank produced its anxiolytic effects without sedation, dependency, or withdrawal symptoms. Selank is registered as a nootropic and anxiolytic pharmaceutical in Russia and Ukraine, supported by multiple human clinical studies.

Human Clinical Data Anxiety Reduction No Sedation
Selank Cognitive Research Human Clinical

Peptide Anxiolytic Selank in Generalised Anxiety Disorder and Neurasthenia

Zh. Nevrologii i Psikhiatrii · Zozulya et al., 2008

A comparative clinical trial of 62 patients with generalised anxiety disorder and neurasthenia, comparing Selank (a tuftsin-derived heptapeptide) against the benzodiazepine medazepam. Selank produced anxiolytic efficacy comparable to medazepam on the Hamilton and Zung scales, with additional antiasthenic effects and without the sedation or dependence liability associated with benzodiazepines.

Anxiolytic GABAergic Human Clinical
Selank Cognitive Research In-Vitro

Selank: GABA-Ergic Modulation and Neurotrophic Factor Research

Neurochemical Journal · Semenova et al., 2010

Selank is a synthetic heptapeptide analogue of immunomodulatory peptide Tuftsin. In-vitro research has investigated its effects on GABA-ergic transmission mechanisms and its potential role in modulating Brain-Derived Neurotrophic Factor (BDNF) expression in cellular models. Research is conducted exclusively in controlled laboratory environments.

GABA-ergic BDNF Immunopeptide
View the full research library →

You may also like